RIMADYL 75MG CHEWABLE TABLETS FOR DOGS

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

지금 구매하세요

Download 환자 정보 전단 (PIL)
20-06-2017
Download 제품 특성 요약 (SPC)
20-06-2017

유효 성분:

CARPROFEN

제공처:

ZOETIS AUSTRALIA PTY LTD

INN (국제 이름):

carprofen(75mg/Tb)

약제 형태:

ORAL TABLET

구성:

CARPROFEN ANTI-INFLAMMATORY-NONSTEROIDAL Active 75.0 mg/Tb

패키지 단위:

14 Tablets; 60 Tablets

수업:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

치료 그룹:

DOG | BITCH | CASTRATE | PUPPY

치료 영역:

MUSCULOSKELETAL SYSTEM

치료 징후:

ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING

제품 요약:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; A non-steroidal anti-inflammatory drug for the relief of pain and inflammation in dogs.Should NOT be used in dogs exhibiting hypersensitivity to carprofen. Use of this product in cats is contraindicated.

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

                                BATCH
EXP
Each tablet contains
75 MG CARPROFEN
A non-steroidal anti-inflammatory drug
for the relief of pain and inflammation in dogs
14 CHEWABLE TABLETS
75 MG
P
0
01
0
3 - L - 0 0
0
Pfizer Animal Health
A division of Pfizer Australia Pty Ltd.
Wharf Rd, West Ryde. 2114
®
Pfizer trademark © 2008
Made in USA
READ THE ENCLOSED LEAFLET BEFORE
USING THIS PRODUCT.
DIRECTIONS FOR USE:
DOSAGE: 2–4 mg/kg bodyweight per day.
Dose, frequency and duration of treatment
will be dependent upon clinical response.
See leaflet for full details.
APVMA: 52469/14/0508
LA3118B
8547051
STORAGE: Store below 25°C (Air Conditioning)
in a dry place out of direct sunlight.
®
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Code No. MH/DRUGS/PD/149
CHEWABLE TABLETS FOR DOGS
File Name: 52469_44705_14 tabs_Primary_MPL_V01.pdf
Dimension: 31mm x 95mm
Date: V01, 0508
Scale: 100% A4
APPROVED
LABEL
Info
PEST

Verified
BATCH
EXP
Pfizer Animal Health
A division of Pfizer Australia Pty Ltd.
Wharf Rd, West Ryde. 2114
®
Pfizer trademark © 2008
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE:
DOSAGE: 2–4 mg/kg bodyweight per day. Dose, frequency and
duration of treatment will be dependent upon clinical response.
See leaflet for full details.
STORAGE: Store below 25°C (Air Conditioning) in a dry place out of
direct sunlight.
APVMA: 52469/60/0508
LA3119B
8503051
Each tablet contains
75 MG CARPROFEN
A non-steroidal
anti-inflammatory drug
for the relief of pain and
inflammation in dogs
60 CHEWABLE TABLETS
75 MG
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Made in USA
P
00
1
04
-
L - 0
0
0
®
Code No. MH/DRUGS/PD/149
CHEWABLE TABLETS FOR DOGS
File Name: 52469_44705_60 tabs_Primary_MPL_V01.pdf
Dimension: 69mm x 107mm
Date: V01, 0508
Scale: 100% A4
APPROVED
LABEL
RIMADYL
®
25 MG CHEWABLE TABLETS FOR DOGS
RIMADYL
®
75 MG CHEWABLE TABLETS FOR DOGS
RIMADYL
®
100 MG CHEWABLE TABLETS FOR DOGS
Rimadyl Chewable Tablets are light brown tablets with a bisect on
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                PRODUCT NAME: RIMADYL CHEWABLE TABLETS
PAGE: 1 OF 4
THIS REVISION ISSUED: AUGUST, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: 1800 814 883
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
- IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: 1800 814 883
Fax: (02) 9850 3399
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Carprofen is a non-steroidal anti-inflammatory ingredient.
TRADE NAME:
RIMADYL CHEWABLE TABLETS
PRODUCT USE:
Analgesia and relief of chronic inflammation in joint diseases in
dogs.
CREATION DATE:
SEPTEMBER, 2006
THIS VERSION ISSUED:
AUGUST, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S45. In case of accident or if you feel unwell, contact a doctor or
Poisons Information Centre
immediately (show the label where possible).
SUSMP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Light brown tablets.
ODOUR:
Characteristic odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION:
SHORT TERM EXPOSURE:
Long term inhalation of high amounts of any nuisance dust may overload
lung clearance
mechanism. Available data indicates that this product is not harmful.
In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No 
                                
                                전체 문서 읽기